AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Capto s impact3/5/2023 Please note, the terms and conditions relating to service, product sales, promotions, and other related activities can be found at, and those terms and conditions control any purchases of products or services from the Company. These Terms and Conditions apply only to the use of the Web Site. Not all of the products or services described in this Web Site are available in all jurisdictions or to all potential customers, and nothing herein is intended as an offer or solicitation in any jurisdiction or to any potential customer where such offer or sale is not qualified. Although the information is believed to correct at the time of publishing, you should make your own determination as to its suitability for your use. The information contained on this Web Site is provided for informational purposes only. If you disagree with the Terms of Use (as amended from time to time) or are dissatisfied with the Web Site, your sole and exclusive remedy is to discontinue using the Web Site. Your continued use of the Web Site means that you accept and agree to the revised Terms of Use. The Company may revise and update these Terms of Use at any time without notice by posting the amended terms to the Web Site. If you do not wish to agree to these Terms of Use, do not access or use any part of the Web Site. By accessing or using the Web Site, you agree that you have read, understand and agree to be bound by these Terms of Use, as amended from time to time, as well as the Company Privacy Policy, which is hereby incorporated into these Terms of Use. Please read these Terms of Use carefully before accessing or using any part of the Web Site. All users of the Web Site are subject to the following website terms and conditions of use (these “Terms of Use”). If you are accessing the Web Site from outside the United States, Canada, or Puerto Rico, please see the appropriate international website, available at for applicable terms and conditions. These terms and conditions of use are applicable to the United States, Canada and Puerto Rico websites (“collectively the Web Site”) operated by VWR (the “Company”). HALO® Chromatography Columns and Consumables+. Sartorius laboratory instruments, consumables and services PerkinElmer - Innovating for a Healthier World Quality Products from Sheldon ManufacturingĪgilent Chemistries and Supplies Portfolio Life Science Research Solutions, Products, and Resources VWR will support you from the latest life science products to the guaranteed purity of organic building blocks. Finally, the percentage of aggregates in a mAb feed was varied to examine the effect on the removal of aggregates with Eshmuno® CP-FT resin using a continuous loading process.A strong, vibrant research and development group is the lifeblood of all industries. The influence of pH, conductivity, residence time, and mAb concentration on the removal of aggregates with Eshmuno® CP-FT resin using a continuous loading process was also investigated. The removal of mAb aggregates with Eshmuno® CP-FT resin using a continuous loading process was compared with six other commercially available strong CEX chromatography resins and found to correlate with their ionic densities, but not their mAb static binding capacities. The removal of mAb aggregates with Eshmuno® CP-FT resin using a continuous loading process was found to be consistent with a frontal chromatography mechanism where the mAb monomer initially binds to the column and is subsequently displaced by dimers and higher molecular weight aggregates. Removing mAb aggregates with a CEX resin using continuous loading is advantageous relative to a bind/elute loading process, because the resin can use nearly its full capacity to bind the aggregates enabling much higher loadings. A low ligand density cation exchange (CEX) chromatography resin, Eshmuno® CP-FT resin, was investigated for the removal of aggregates from monoclonal antibody (mAb) feeds using a continuous loading process.
0 Comments
Read More
Leave a Reply. |